| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 5 |
| 1 | ASPIRIN | 4 |
| 2 | ASPIRIN 325 MG | 4 |
| 3 | ASPIRIN 81 MG | 4 |
| 4 | DIPHENHYDRAMINE HYDROCHLORIDE | 4 |
| 5 | ACETAMINOPHEN | 3 |
| 6 | IVACAFTOR | 3 |
| 7 | METHYLPREDNISOLONE | 3 |
| 8 | PANTOPRAZOLE | 3 |
| 9 | RITUXIMAB-ABBS | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RITUXIMAB-ABBS | 3 | 0.0006 |
| 1 | PLECANATIDE | 1 | 0.0005 |
| 2 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| 3 | CYPROHEPTADINE HYDROCHLORIDE | 1 | 0.0002 |
| 4 | NORETHINDRONE | 1 | 0.0002 |
| 5 | BECLOMETHASONE DIPROPIONATE | 1 | 0.0002 |
| 6 | PANCRELIPASE LIPASE, PANCRELIPASE PROTEASE, PANCRELIPASE AMYLASE | 1 | 0.0002 |
| 7 | AZTREONAM | 1 | 0.0001 |
| 8 | PHYTONADIONE | 1 | 0.0001 |
| 9 | CAPTOPRIL | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 1 | Monobactam Antibacterial [EPC] | 1 | 0.0004 |
| 2 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 3 | 0.0002 |
| 3 | Vitamin K [EPC] | 1 | 0.0001 |
| 4 | Recombinant Human Deoxyribonuclease 1 [EPC] | 2 | 0.0001 |
| 5 | Complement Inhibitor [EPC] | 2 | 0.0000 |
| 6 | Leukotriene Receptor Antagonist [EPC] | 1 | 0.0000 |
| 7 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 8 | Oxazolidinone Antibacterial [EPC] | 1 | 0.0000 |
| 9 | Rifamycin Antibacterial [EPC] | 1 | 0.0000 |